Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation

被引:239
作者
Oupicky, D [1 ]
Ogris, M
Howard, KA
Dash, PR
Ulbrich, K
Seymour, LW
机构
[1] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
[2] Acad Sci Czech Republ, Inst Macromol Chem, Prague, Czech Republic
基金
英国生物技术与生命科学研究理事会;
关键词
in vivo; pharmacokinetics; polyplexes; polylysine; polyethylenimine; steric stabilization; lateral stabilization; PEG; HPMA; gene delivery;
D O I
10.1006/mthe.2002.0568
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Gene therapy for systemic diseases requires intravenous administration, but existing vectors are not suitable for systemic delivery, often showing rapid elimination from the bloodstream that restricts potential transfection sites to "first-pass" organs. To develop long-circulating vectors, here we have compared polyplexes containing DNA and poly-L-lysine (PLL) or polyethylenimine (PEI), surface-modified with either monovalent polyethylene glycol (PEG) or multivalent copolymers of N-(2-hydroxypropyl)methacrylamide (PHPMA), correlating their biophysical properties with their distribution following intravenous injection. A key difference between the two types of coating is the introduction of lateral stabilization by surface attachment of multivalent PHPMA, in addition to the steric stabilization provided by both types of polymers. The a-half-life for bloodstream clearance of polycation/DNA polyplexes (typically < 5 minutes in mice) could be extended using multivalent PHPMA coating to > 90 minutes. We found that the dose administered, as well as the amount and molecular weight of the coating PHPMA, had important effects on circulation properties. Multivalent PHPMA coating allows, for the first time, considerably extended circulation time using polyplex systems-a prerequisite for systemic gene delivery.
引用
收藏
页码:463 / 472
页数:10
相关论文
共 43 条
[1]   Blood clearance rates of adenovirus type 5 in mice [J].
Alemany, R ;
Suzuki, K ;
Curiel, DT .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :2605-2609
[2]   Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration [J].
Barron, LG ;
Gagné, L ;
Szoka, FC .
HUMAN GENE THERAPY, 1999, 10 (10) :1683-1694
[3]   Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid DNA complexes [J].
Barron, LG ;
Meyer, KB ;
Szoka, FC .
HUMAN GENE THERAPY, 1998, 9 (03) :315-323
[4]   Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes [J].
Bettinger, T ;
Remy, JS ;
Erbacher, P .
BIOCONJUGATE CHEMISTRY, 1999, 10 (04) :558-561
[5]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[6]   Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin [J].
Dash, PR ;
Read, ML ;
Fisher, KD ;
Howard, KA ;
Wolfert, M ;
Oupicky, D ;
Subr, V ;
Strohalm, J ;
Ulbrich, K ;
Seymour, LW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :3793-3802
[7]   Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].
Dash, PR ;
Read, ML ;
Barrett, LB ;
Wolfert, M ;
Seymour, LW .
GENE THERAPY, 1999, 6 (04) :643-650
[8]  
Drummond DC, 1999, PHARMACOL REV, V51, P691
[9]  
Erbacher P, 1999, J GENE MED, V1, P210
[10]   A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression [J].
Fisher, KD ;
Ulbrich, K ;
Subr, V ;
Ward, CM ;
Mautner, V ;
Blakey, D ;
Seymour, LW .
GENE THERAPY, 2000, 7 (15) :1337-1343